#canopy Community Insights & Market Sentiment

·

--

$CANOPY RAISES $8.5M SEED FROM ARRINGTON CAPITAL, FENBUSHI & MORE 🚀

AI-powered Web3 infrastructure layer Canopy just closed an $8.5M seed round backed by Arrington Capital, Fenbushi, Borderless Capital, and SNZ Capital. That's a strong list of institutional names betting on the intersection of AI and decentralized infrastructure.

The funds are earmarked for mainnet launch, engineering hires, and native AI tooling. Early stage commitments from funds like this usually signal conviction before the broader market catches on.

Are you watching the AI x Web3 narrative this cycle?

Not financial advice. Always manage your risk.

#CANOPY #Web3 #AI #SeedRound #CryptoInfrastructure

🔥

C-ICT Trader

·

--

$CANOPY SECURES $8.5M SEED ROUND FROM TOP VENTURE FIRMS 💎

The injection of capital from Arrington Capital and Fenbushi Capital signals strong institutional confidence in Canopy's AI-driven Web3 infrastructure layer. This funding is allocated specifically for mainnet launch, engineering expansion, and native AI tool development — key catalysts that could drive liquidity and network adoption.

With $8.5M in fresh reserves, the project now has the runway to build real utility. The question is whether this will accelerate token demand or just extend development timelines.

Not financial advice. Always manage your risk.

#CANOPY #SeedRound #Web3 #AI #Infrastructure

💎

GALAXY 7

·

--

Article

Major cannabis stocks surge Friday after reports Trump is expected to sign executive order

Major cannabis stocks surge Friday after reports Trump is expected to sign executive order to reclassify marijuana.
Stock Performance Highlights
Canopy Growth (WEED: TSE) shares jumped more than 50% in single-day trading on Friday, closing at $2.40 CAD per share, up significantly from its previous close of $1.57 CAD.
Tilray Brands (TLRY: NASDAQ) stock climbed over 55%, closing at $12.15 USD. Its shares added another 11% in after-hours trading.
Aurora Cannabis (ACB: TSE) stock rose nearly 17%, closing at $7.44 CAD per share.
Industry Impact
The potential reclassification of cannabis from a Schedule I to a Schedule III drug would represent a significant shift in U.S. federal policy, acknowledging its medical use and lowering its perceived potential for abuse.
This regulatory change could ease several burdens for cannabis companies, including:
Tax relief: It would likely alleviate some of the heavy tax burdens currently faced by cannabis businesses.
Banking access: It could facilitate easier access to mainstream banking services and capital from lenders and investors.
Research opportunities: The change would bolster opportunities for medical research into cannabis.
The news triggered broad gains across the sector, with the CNBS cannabis ETF and the Amplify Alternative Harvest ETF (MJ) also recording their best single-day performances ever.
We can track the performance of these and other cannabis stocks as the potential executive order unfolds. Would you like to focus on the impact on a specific company's financials, such as Canopy Growth's revenue or net income?
#Marijuana #pot #Canopy #Tilray #Cannabis

canopy

Major cannabis stocks surge Friday after reports Trump is expected to sign executive order

Trending Topics